Cargando…

Antisera Produced Using an E. coli-Expressed SARS-CoV-2 RBD and Complemented with a Minimal Dose of Mammalian-Cell-Expressed S1 Subunit of the Spike Protein Exhibits Improved Neutralization

E. coli-expressed proteins could provide a rapid, cost-effective, and safe antigen for subunit vaccines, provided we can produce them in a properly folded form inducing neutralizing antibodies. Here, we use an E. coli-expressed SARS-CoV-2 receptor-binding domain (RBD) of the spike protein as a model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshizue, Takahiro, Brindha, Subbaian, Wongnak, Rawiwan, Takemae, Hitoshi, Oba, Mami, Mizutani, Tetsuya, Kuroda, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341788/ https://www.ncbi.nlm.nih.gov/pubmed/37445760 http://dx.doi.org/10.3390/ijms241310583

Ejemplares similares

An Escherichia coli Expressed Multi-Disulfide Bonded SARS-CoV-2 RBD Shows Native-like Biophysical Properties and Elicits Neutralizing Antisera in a Mouse Model
por: Brindha, Subbaian, et al.
Publicado: (2022)

A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in E. coli Using a SEP-Tag Produces Antisera Interacting with the Mammalian Cell Expressed Spike (S1) Protein
por: Brindha, Subbaian, et al.
Publicado: (2022)

Development of a new quantification method of Sarcocystis cruzi through detection of the acetyl-CoA synthetase gene
por: DOI, Rie, et al.
Publicado: (2022)

Development of a one-run real-time PCR detection system for pathogens associated with poultry infectious diseases
por: SHIBANUMA, Takuya, et al.
Publicado: (2023)

Antisera by the Mouth
por: Basu, K. M.
Publicado: (1932)

Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
por: Herrlein, Marie-Luise, et al.
Publicado: (2022)

Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells
por: De March, Matteo, et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein (RBD) Subunit Adsorption at Abiotic Surfaces and Corona Formation at Polymer Particles
por: Żeliszewska, Paulina, et al.
Publicado: (2022)

ATeam technology for detecting early signs of viral cytopathic effect
por: DOYSABAS, Karla Cristine C., et al.
Publicado: (2020)

Improved Expression of SARS-CoV-2 Spike RBD Using the Insect Cell-Baculovirus System
por: Poodts, Joaquín, et al.
Publicado: (2022)

Expression, purification and production of antisera against recombinant truncated VP22 protein
por: YU, XIAN, et al.
Publicado: (2016)

ANTINUCLEAR ANTIBODIES IN RABBIT ANTISERA
por: Barnett, Eugene V., et al.
Publicado: (1966)

STUDIES ON RABBIT LYMPHOCYTES IN VITRO : V. THE INDUCTION OF BLAST TRANSFORMATION WITH SHEEP ANTISERA TO RABBIT IGG SUBUNITS
por: Sell, Stewart
Publicado: (1967)

First Isolation and Identification of Homologous Recombination Events of Porcine Adenovirus from Wild Boar
por: Oba, Mami, et al.
Publicado: (2022)

Utilization of Recombinant Baculovirus Expression System to Produce the RBD Domain of SARS-CoV-2 Spike Protein
por: Fan, Youpeng, et al.
Publicado: (2022)

Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays
por: Uma, Madala, et al.
Publicado: (2016)

ANTISERA, TOXOIDS, VACCINES AND TUBERCULINS IN PROPHYLAXIS AND TREATMENT
Publicado: (1955)

ANTISERA, TOXOIDS, VACCINES AND TUBERCULIN IN PROPHYLAXIS AND TREATMENT
Publicado: (1958)

ANTISERA, TOXOIDS, VACCINES AND TUBERCULINS IN PROPHYLAXIS AND TREATMENT
Publicado: (1961)

ANTISERA, TOXOIDS, VACCINES AND TUBERCULINS IN PROPHYLAXIS AND TREATMENT
Publicado: (1962)

THE INHIBITION OF STREPTOCOCCAL DESOXYRIBONUCLEASE BY RABBIT AND HUMAN ANTISERA
por: McCarty, Maclyn
Publicado: (1949)

MACROGLOBULINEMIA : II. ANTISERA SPECIFIC FOR PATHOLOGICAL MACROGLOBULINS
por: Korngold, Leonhard, et al.
Publicado: (1957)

STUDIES ON HEMAGGLUTINATION AND HEMOLYSIS BY ESCHERICHIA COLI ANTISERA
por: Neter, Erwin, et al.
Publicado: (1952)

Inhibition of T-antigen-binding cells by idiotypic antisera
Publicado: (1977)

The Use of the Domestic Fowl for the Preparation of Diagnostic Antisera
por: Pasricha, C. L., et al.
Publicado: (1939)

Generation of therapeutic antisera for emerging viral infections
por: Schmidt, Rebecca, et al.
Publicado: (2018)

The Immunogenicity of DENV1–4 ED3s Strongly Differ despite Their Almost Identical Three-Dimensional Structures and High Sequence Similarities
por: Islam, Md. Din, et al.
Publicado: (2023)

Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials
por: Blanco, Omar R., et al.
Publicado: (2022)

A COMPARISON OF HUMAN ANTISERA TO PURIFIED DIPHTHERIA TOXOID WITH ANTISERA TO OTHER PURIFIED ANTIGENS BY QUANTITATIVE PRECIPITIN AND GEL DIFFUSION TECHNIQUES
por: Finger, Irving, et al.
Publicado: (1958)

Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera
Publicado: (1976)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
por: Sun, Yi-Sheng, et al.
Publicado: (2021)

STUDIES ON RABBIT LYMPHOCYTES IN VITRO : II. INDUCTION OF BLAST TRANSFORMATION WITH ANTISERA TO SIX IGG ALLOTYPES AND SUMMATION WITH MIXTURES OF ANTISERA TO DIFFERENT ALLOTYPES
por: Gell, P. G. H., et al.
Publicado: (1965)

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
por: Ni, Tao, et al.
Publicado: (2023)

Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
por: Nagar, Gaurav, et al.
Publicado: (2023)

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
por: Pérez-Bernal, Maylin, et al.
Publicado: (2022)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

LYMPHOCYTE-MEDIATED CYTOTOXICITY IN VITRO : EFFECT OF ENHANCING ANTISERA
por: Klein, William J.
Publicado: (1971)

STUDIES OF IDIOTYPIC ANTIBODIES : PRODUCTION AND CHARACTERIZATION OF AUTOANTIIDIOTYPIC ANTISERA
por: Rodkey, L. Scott
Publicado: (1974)

OBSERVATIONS ON THE AGGLUTINATION OF POLYSACCHARIDE-TREATED ERYTHROCYTES BY TULAREMIA ANTISERA
por: Alexander, Mary M., et al.
Publicado: (1950)

Production of Monospecific Rabbit Antisera Recognizing Nidovirus Proteins
por: Zevenhoven-Dobbe, Jessika C., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_907n8u380lgg2s0a5bdvckd48g